These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11758678)

  • 1. Variable clinical presentation in lysosomal storage disorders.
    Beck M
    J Inherit Metab Dis; 2001; 24 Suppl 2():47-51; discussion 45-6. PubMed ID: 11758678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAAMP 2.0: An algorithm to predict genotype-phenotype correlation of lysosomal storage diseases.
    Ou L; Przybilla MJ; Whitley CB
    Clin Genet; 2018 May; 93(5):1008-1014. PubMed ID: 29396849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal storage disorders in Thailand: the Siriraj experience.
    Wasant P; Wattanaweeradej S; Raksadawan N; Kolodny EH
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():54-8. PubMed ID: 8629143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [beta-galactosidosis--GM1 gangliosidosis and Morquio B disease].
    Yoshida K; Yanagisawa N
    Nihon Rinsho; 1995 Dec; 53(12):2960-6. PubMed ID: 8577043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies.
    Santamaria R; Chabás A; Coll MJ; Miranda CS; Vilageliu L; Grinberg D
    Hum Mutat; 2006 Oct; 27(10):1060. PubMed ID: 16941474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease.
    Suzuki Y
    Brain Dev; 2013 Jun; 35(6):515-23. PubMed ID: 23290321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A beta-galactosidase gene mutation identified in both Morquio B disease and infantile GM1 gangliosidosis.
    Suzuki Y; Oshima A
    Hum Genet; 1993 May; 91(4):407. PubMed ID: 8500799
    [No Abstract]   [Full Text] [Related]  

  • 8. Lysosomal storage disorders affecting the heart: a review.
    Nair V; Belanger EC; Veinot JP
    Cardiovasc Pathol; 2019; 39():12-24. PubMed ID: 30594732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
    Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
    Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can cell biology tell us about heterogeneity in lysosomal storage diseases?
    Gieselmann V
    Acta Paediatr Suppl; 2005 Mar; 94(447):80-6; discussion 79. PubMed ID: 15895717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular heterogeneity in hereditary beta-galactosidase deficiency.
    Suzuki Y; Sakuraba H; Oshima A; Yoshida K; Shimmoto M; Takano T; Fukuhara Y
    Dev Neurosci; 1991; 13(4-5):299-303. PubMed ID: 1817034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?
    Maire I
    J Inherit Metab Dis; 2001; 24 Suppl 2():57-61; discussion 45-6. PubMed ID: 11758680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morquio B syndrome: a primary defect in beta-galactosidase.
    van der Horst GT; Kleijer WJ; Hoogeveen AT; Huijmans JG; Blom W; van Diggelen OP
    Am J Med Genet; 1983 Oct; 16(2):261-75. PubMed ID: 6418007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analyses in 17 patients with deficiency in acid beta-galactosidase: three novel point mutations and high correlation of mutation W273L with Morquio disease type B.
    Paschke E; Milos I; Kreimer-Erlacher H; Hoefler G; Beck M; Hoeltzenbein M; Kleijer W; Levade T; Michelakakis H; Radeva B
    Hum Genet; 2001 Aug; 109(2):159-66. PubMed ID: 11511921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitotriosidase as a biomarker for gangliosidoses.
    Kim S; Whitley CB; Jarnes JR
    Mol Genet Metab Rep; 2021 Dec; 29():100803. PubMed ID: 34646735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are GMI gangliosidosis and Morquio type B two different disorders or part of one phenotypic spectrum?
    Kingma SDK; Ceulemans B; Kenis S; Jonckheere AI
    JIMD Rep; 2021 May; 59(1):90-103. PubMed ID: 33977034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Change of isoforms' spectrum of alpha-L-fucoside secreted by affected cells in some hereditary lysosomal diseases].
    Ivleva TS; Beíer EM; Ushakova NA; Malakhova VA; Karpova EA; Tsvetkova IV
    Vopr Med Khim; 1997; 43(3):177-84. PubMed ID: 9273782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structural basis for β-galactosidase associated with lysosomal disease].
    Shimizu T
    Yakugaku Zasshi; 2013; 133(5):509-17. PubMed ID: 23649392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal storage diseases presenting as transient or persistent hydrops fetalis.
    Bonduelle M; Lissens W; Goossens A; De Catte L; Foulon W; Denis R; Jauniaux E; Liebaers I
    Genet Couns; 1991; 2(4):227-32. PubMed ID: 1799421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital Heart Malformations Masked by Infantile Gangliosidosis-Case Report and Growing Evidence for Metabolic Disease-Associated Aortopathies.
    Mîndru DE; Țarcă E; Braha EE; Curpăn AȘ; Roșu ST; Anton-Păduraru DT; Adumitrăchioaiei H; Bernic V; Pădureț IA; Luca AC
    Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.